YLZ-F-5

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameYLZ-F-5
Drug Alias NameYLZ-F-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolo like kinase 4 inhibitors
TargetsPolo like kinase 4
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesSichuan University
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A